HEALTH● ELEVATED22h ago · Sep 1, 2026, 5:28 AM
Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ
Seeking Alpha Tech · global
Novartis has halted trials for autoimmune CAR-T therapies after three patient deaths were reported. This action impacts the development of a new treatment type and raises concerns about patient safety in clinical trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoAndhra CM orders inquiry after villagers fall ill following anti-malaria drug distributionThe HinduHEALTH1h agoSt . Bernards to use $14 . 5 million in state funding for regional health network , technologykait8.com · United StatesHEALTH1h agoCM revamps J & K cancer treatment , management fund for poorkashmirreader.com · IndiaHEALTH1h agoCrooner Lionel Richie remains in hospitalmaitlandmercury.com.au · Australia